Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Duchenne | 9 | 2025 | 39 | 3.410 |
Why?
|
| Muscle, Skeletal | 5 | 2024 | 473 | 1.740 |
Why?
|
| Angiopoietin-1 | 2 | 2024 | 7 | 1.380 |
Why?
|
| Utrophin | 3 | 2025 | 4 | 1.370 |
Why?
|
| Mice, Inbred mdx | 6 | 2025 | 15 | 1.360 |
Why?
|
| Receptors, Ghrelin | 2 | 2025 | 5 | 1.020 |
Why?
|
| Myocardium | 2 | 2025 | 567 | 0.740 |
Why?
|
| Inflammation | 1 | 2025 | 1049 | 0.590 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2021 | 2562 | 0.570 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 2479 | 0.550 |
Why?
|
| Dystrophin | 3 | 2023 | 24 | 0.510 |
Why?
|
| Molecular Imaging | 2 | 2014 | 72 | 0.460 |
Why?
|
| Brain Neoplasms | 5 | 2022 | 810 | 0.450 |
Why?
|
| Mice | 13 | 2025 | 12230 | 0.440 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2014 | 19 | 0.430 |
Why?
|
| Glioma | 4 | 2021 | 298 | 0.410 |
Why?
|
| Fibrosis | 1 | 2015 | 228 | 0.400 |
Why?
|
| Myoblasts | 1 | 2013 | 33 | 0.380 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 64 | 0.380 |
Why?
|
| Animals | 22 | 2025 | 27973 | 0.380 |
Why?
|
| Stem Cells | 2 | 2005 | 386 | 0.380 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2014 | 332 | 0.350 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 192 | 0.350 |
Why?
|
| Neovascularization, Pathologic | 3 | 2024 | 353 | 0.340 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 183 | 0.330 |
Why?
|
| Ghrelin | 2 | 2025 | 27 | 0.330 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 626 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2024 | 391 | 0.300 |
Why?
|
| Chemokines | 2 | 1999 | 76 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 3431 | 0.280 |
Why?
|
| Central Nervous System | 2 | 1999 | 139 | 0.280 |
Why?
|
| Cell Culture Techniques | 2 | 2005 | 195 | 0.260 |
Why?
|
| Blood Glucose | 1 | 2011 | 866 | 0.250 |
Why?
|
| Mice, Knockout | 3 | 2025 | 2121 | 0.250 |
Why?
|
| Biomarkers | 4 | 2025 | 1905 | 0.250 |
Why?
|
| Positron-Emission Tomography | 4 | 2023 | 347 | 0.230 |
Why?
|
| X Chromosome Inactivation | 1 | 2005 | 30 | 0.230 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2025 | 87 | 0.220 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2024 | 78 | 0.210 |
Why?
|
| Embryonic Stem Cells | 1 | 2005 | 85 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2023 | 2 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 105 | 0.200 |
Why?
|
| Male | 11 | 2025 | 44355 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2024 | 477 | 0.170 |
Why?
|
| Muscular Dystrophy, Animal | 2 | 2013 | 21 | 0.170 |
Why?
|
| Glucose | 2 | 2022 | 686 | 0.170 |
Why?
|
| Pyruvic Acid | 1 | 2021 | 12 | 0.170 |
Why?
|
| Multiple Sclerosis | 1 | 2023 | 260 | 0.170 |
Why?
|
| Rats, Wistar | 5 | 2022 | 300 | 0.160 |
Why?
|
| Perfusion Imaging | 3 | 2016 | 48 | 0.160 |
Why?
|
| Glioblastoma | 1 | 2022 | 280 | 0.160 |
Why?
|
| Poliomyelitis | 1 | 1999 | 12 | 0.160 |
Why?
|
| Theilovirus | 1 | 1999 | 15 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 367 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 300 | 0.150 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 61 | 0.140 |
Why?
|
| Iron | 1 | 2019 | 173 | 0.140 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 1998 | 66 | 0.140 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 1276 | 0.140 |
Why?
|
| Genes, Reporter | 2 | 2019 | 275 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 1909 | 0.130 |
Why?
|
| Microscopy | 1 | 2017 | 88 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 981 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 83 | 0.110 |
Why?
|
| Disease Progression | 2 | 2017 | 1529 | 0.110 |
Why?
|
| Tomography, Emission-Computed | 1 | 2014 | 104 | 0.110 |
Why?
|
| Hindlimb | 1 | 2015 | 94 | 0.110 |
Why?
|
| Diaphragm | 1 | 2015 | 75 | 0.100 |
Why?
|
| Rats | 5 | 2022 | 4028 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 167 | 0.100 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 213 | 0.100 |
Why?
|
| Collagen | 1 | 2015 | 301 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 448 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2014 | 468 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 2705 | 0.090 |
Why?
|
| Transfection | 1 | 2013 | 877 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2014 | 1611 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 312 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2014 | 319 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2022 | 145 | 0.080 |
Why?
|
| Hypoxia | 1 | 2016 | 672 | 0.080 |
Why?
|
| Glycolysis | 2 | 2022 | 186 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1160 | 0.080 |
Why?
|
| Fas Ligand Protein | 1 | 2009 | 47 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 1517 | 0.070 |
Why?
|
| Piperidines | 1 | 2010 | 163 | 0.070 |
Why?
|
| Quinazolines | 1 | 2010 | 211 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 2757 | 0.070 |
Why?
|
| Respiratory System | 1 | 2009 | 117 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1732 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1703 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 578 | 0.060 |
Why?
|
| Teratogens | 1 | 2005 | 11 | 0.060 |
Why?
|
| Embryo Research | 1 | 2005 | 7 | 0.060 |
Why?
|
| Brain | 1 | 2016 | 2337 | 0.060 |
Why?
|
| Aneuploidy | 1 | 2005 | 59 | 0.060 |
Why?
|
| Cytogenetic Analysis | 1 | 2005 | 70 | 0.060 |
Why?
|
| RNA, Untranslated | 1 | 2005 | 67 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 3450 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 526 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2005 | 177 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 217 | 0.050 |
Why?
|
| Azacitidine | 1 | 2005 | 149 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2005 | 129 | 0.050 |
Why?
|
| Telomere | 1 | 2005 | 119 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 1171 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2023 | 38 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2023 | 98 | 0.050 |
Why?
|
| Pyruvates | 1 | 2022 | 12 | 0.050 |
Why?
|
| Chromatin | 1 | 2005 | 440 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 479 | 0.040 |
Why?
|
| Asthma | 1 | 2009 | 1039 | 0.040 |
Why?
|
| Cytokines | 2 | 2009 | 862 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 2458 | 0.040 |
Why?
|
| Contrast Media | 2 | 2019 | 986 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2023 | 1129 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 108 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1999 | 10 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 1999 | 15 | 0.040 |
Why?
|
| Sex Factors | 1 | 2023 | 1102 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 1999 | 13 | 0.040 |
Why?
|
| Chemokine CCL4 | 1 | 1999 | 10 | 0.040 |
Why?
|
| Humans | 7 | 2021 | 93132 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 1999 | 22 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 1999 | 23 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 1999 | 36 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 1999 | 45 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 201 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2019 | 14 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 260 | 0.040 |
Why?
|
| Multipotent Stem Cells | 1 | 2019 | 20 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1022 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 888 | 0.030 |
Why?
|
| Time Factors | 2 | 2010 | 5380 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1304 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1719 | 0.030 |
Why?
|
| Female | 3 | 2023 | 48542 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1999 | 2020 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 2014 | 156 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2014 | 305 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 305 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 696 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 458 | 0.020 |
Why?
|
| Rats, Nude | 1 | 2010 | 27 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1994 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 2889 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2009 | 18 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 173 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 368 | 0.020 |
Why?
|
| Point Mutation | 1 | 2009 | 237 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 278 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2009 | 351 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1463 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 710 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2010 | 498 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 679 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1948 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 556 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1581 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 606 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2827 | 0.010 |
Why?
|